Macquarie Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $36M | Buy |
|
|||||
|
2025
Q2 | $403K | Sell |
|
|||||
|
2025
Q1 | $7.76M | Buy |
|
|||||
|
2024
Q4 | $7.33M | Buy |
|
|||||
|
2024
Q3 | $672K | Buy |
|
|||||
|
2024
Q2 | $477K | Sell |
|
|||||
|
2024
Q1 | $9.38M | Buy |
|
|||||
|
2023
Q4 | $6.74M | Buy |
|
|||||
|
2023
Q3 | $3M | Sell |
|
|||||
|
2023
Q2 | $3.34M | Sell |
|
|||||
|
2023
Q1 | $4.33M | Buy |
|
|||||
|
2022
Q4 | $1.51M | Sell |
|
|||||
|
2022
Q3 | $2.08M | Buy |
|
|||||
|
2022
Q2 | $1.23M | Buy |
|
|||||
|
2022
Q1 | $345 | Sell |
|
|||||
|
2021
Q4 | $493K | Sell |
|
|||||
|
2021
Q3 | $849K | Sell |
|
|||||
|
2021
Q2 | $887K | Buy |
|
|||||
|
2021
Q1 | $515K | Sell |
|
|||||
|
2020
Q4 | $568K | Buy |
|
|||||
|
2020
Q3 | $479K | Buy |
|
|||||
|
2020
Q2 | $352K | Buy |
|
|||||
|
2020
Q1 | $166K | Hold |
|
|||||
|
2019
Q4 | $201K | Sell |
|
|||||
|
2019
Q3 | $405K | Sell |
|
|||||
|
2019
Q2 | $538K | Buy |
|
|||||
|
2019
Q1 | $170K | Buy |
|
|||||
|
2018
Q4 | $11K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $45K | Buy |
|